In order to make patients gain access to effective novel medications Within a reasonable period of time, and
                     In order to make patients feel safe and comfortable when taking medicines, PERSOL PHARMA PARTNERS would thus like to become the most trusted partner
                     not only for patients but for clients. In order to make patients gain access to effective novel medications Within a reasonable period of time, and
                     In order to make patients feel safe and comfortable when taking medicines, PERSOL PHARMA PARTNERS would thus like to become the most trusted partner
                     not only for patients but for clients.

Information on Business Contents

News

2021.5.13

Customer Notification Letter  (PDF:151KB)
Effective April 30, 2021, PERSOL PHARMA PARTNERS CO.,LTD. is now a subsidiary of Syneos Health
Clinical K.K., a full-service CRO in Japan (including ICCC andPMDA/Regulatory Consultation),
offering therapeutic expertise,local expertise andoperational excellence. For more information,
please visit Syneos Health.

 

Before Change)
PERSOL PHARMA PARTNERS CO.,LTD.

 

After Change)
Syneos Pharma Partners Co., Ltd.

2018.4.1

PV NEXT and MEDICROSS merged to become PERSOL PHARMA PARTNERS CO., LTD.

PAGETOP
PAGETOP